Pharmacokinetics of Acetaminophen in the Human Neonate: Formation of Acetaminophen Glucuronide and Sulfate in Relation to Plasma Bilirubin Concentration and D-Glucaric Acid Excretion
1 Department of Pharmaceutics, State University of New York, Buffalo, the Department of Pediatrics, Catherine Booth Hospital, Montreal, and the McGill University-Montreal Children's Hospital Research Institute, Montreal
The purpose of this study was to determine if certain physiologic parameters (plasma bilirubin concentration and urinary excretion rate of D-glucaric acid) can be used to predict a newborn infant's ability to eliminate a phenolic drug. and particularly to predict the ability to conjugate that drug with glucuronic acid. Twelve healthy 2-to 3-day-old full-term infants with plasma bilirubin concentrations of 1.0 to 11.6 mg/100 ml and D-glucaric acid excretion rates of 0.131 to 0.345 mg/kg/day received a single oral dose of acetaminophen, 12 mg/kg. Urine was collected serially for 48 hours and analyzed for acetaminophen, acetaminophen glucuronide, acetaminophen sulfate, and D-glucaric acid. The biologic half-life of acetaminophen was 3.5 ± 0.85 hours (average ± SD) as compared to average values of 1.9 to 2.2 hours observed in five reported studies on a total of 39 adults. The rate constant for acetaminophen glucuronide formation in neonates was considerably smaller, on the average, than in adults but the average rate constant for acetaminophen sulfate formation was somewhat larger than in adults. There is no statistically significant correlation between these rate constants and either plasma bilirubin concentration or D-glucaric acid excretion. The results of this study suggest that the limited ability of neonates to conjugate phenolic drugs with glucuronic acid is compensated to a degree by a well-developed capability for sulfate conjugation.
Submitted on July 31, 1974Accepted on October 18, 1974
This article has been cited by other articles:
![]() |
K. Allegaert and D. Tibboel Comments on "Shift from Biliary to Urinary Elimination of Acetaminophen-Glucuronide in Acetaminophen-Pretreated Rats" J. Pharmacol. Exp. Ther., February 1, 2006; 316(2): 966 - 967. [Full Text] [PDF] |
||||
![]() |
M. D. Miller, M. A. Marty, A. Arcus, J. Brown, D. Morry, and M. Sandy Differences Between Children and Adults: Implications for Risk Assessment at California EPA International Journal of Toxicology, September 1, 2002; 21(5): 403 - 418. [Abstract] [PDF] |
||||
![]() |
G. Ginsberg, D. Hattis, B. Sonawane, A. Russ, P. Banati, M. Kozlak, S. Smolenski, and R. Goble Evaluation of Child/Adult Pharmacokinetic Differences from a Database Derived from the Therapeutic Drug Literature Toxicol. Sci., April 1, 2002; 66(2): 185 - 200. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. W. Hahn, S. W. Henneberg, R. J. Holm-Knudsen, K. Eriksen, S. N. Rasmussen, and M. Rasmussen Pharmacokinetics of rectal paracetamol after repeated dosing in children Br. J. Anaesth., October 1, 2000; 85(4): 512 - 519. [Abstract] [Full Text] [PDF] |
||||
![]() |
R A van Lingen, J T Deinum, J M E Quak, A J Kuizenga, J G van Dam, K J S Anand, D Tibboel, and A Okken Pharmacokinetics and metabolism of rectally administered paracetamol in preterm neonates Arch. Dis. Child. Fetal Neonatal Ed., January 1, 1999; 80(1): 59F - 63. [Abstract] [Full Text] |
||||
![]() |
C. Y. Poon Pain Management and Conscious Sedation for the Pediatric Patient Journal of Pharmacy Practice, February 1, 1996; 9(1): 57 - 74. [Abstract] [PDF] |
||||
![]() |
T. I. McRorie, A. M. Lynn, M. K. Nespeca, K. E. Opheim, and J. T. Slattery The Maturation of Morphine Clearance and Metabolism Arch Pediatr Adolesc Med, August 1, 1992; 146(8): 972 - 976. [Abstract] [PDF] |
||||
![]() |
E. J. Schoen and A. A. Fischell Pain in Neonatal Circumcision Clinical Pediatrics, July 1, 1991; 30(7): 429 - 432. [Abstract] [PDF] |
||||
![]() |
G. Levy Comparative Pharmacokinetics of Aspirin and Acetaminophen Arch Intern Med, February 23, 1981; 141(3): 279 - 281. [Abstract] [PDF] |
||||
![]() |
J. F. Winchester, M. C. Gelfand, M. Helliwell, J. A. Vale, R. Goulding, and G. E. Schreiner Extracorporeal Treatment of Salicylate or Acetaminophen Poisoning--Is There a Role? Arch Intern Med, February 23, 1981; 141(3): 370 - 374. [Abstract] [PDF] |
||||
![]() |
R. G. Peterson and B. H. Rumack Age as a Variable in Acetaminophen Overdose Arch Intern Med, February 23, 1981; 141(3): 390 - 393. [Abstract] [PDF] |
||||
![]() |
D. Rollins, C von Bahr, H Glaumann, P Moldeus, and A Rane Acetaminophen: potentially toxic metabolite formed by human fetal and adult liver microsomes and isolated fetal liver cells Science, September 28, 1979; 205(4413): 1414 - 1416. [Abstract] [PDF] |
||||
![]() |
B. AMEER and D. J. GREENBLATT Acetaminophen Ann Intern Med, August 1, 1977; 87(2): 202 - 209. [Abstract] [PDF] |
||||















